Recently, several retrospective studies of patients with T2D and CKD found that although use of GLP1-RA was associated with improved overall survival compared to use of DPP4i, there was no significant difference in cardiovascular outcomes42,43. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.